CICAD: Inter-American Observatory on Drugs (OID)

Inter-American Observatory on Drugs (OID)

 

The Inter-American Observatory on Drugs (OID) is CICAD's statistical, information, and scientific research branch. Informed by a sound, evidence-based picture of the drug problem, both nationally and at the hemispheric level, member states can better understand all the dimensions of the drug problem, and design and implement policies and programs to address them. The Observatory helps countries to improve the collection and analysis of drug-related data: by promoting the establishment of national observatories and the use of standardized methods and data; and by providing scientific and technical training for, and the exchange of experiences among, professionals working on drug issues. See the relevant guidelines on evidence-based policies and scientific research in the Hemispheric Drug Strategy.

News

Partners organizations

 
PRADICAN

Mission

Our mission is to help promote and build a drug information network for the Americas that offers objective, reliable, up-to-date and comparative information so that member states can better understand, design and implement policies and programs to confront the drug phenomenon in all its dimensions.

Vision

Created in 2000, the Observatory supports hemispheric policy and cooperation by examining the crucial nexus of supply and demand within the hemisphere and vis-a-vis other regions of the world. It has the potential to serve as an early warning system on the appearance of new drugs, new methods of using and manufacturing drugs, and changing trafficking patterns. 

Services:

From its mission and vision, as well as the objectives set, the OID provides technical assistance to member states in order to:

  1. Helping countries improve the collection and analysis of drug-related data;

  2. Promoting the establishment of national drug observatories and the use of standardized data systems and methodologies; and

  3. Providing scientific and technical training for and the exchange of experiences among professionals working on the drug problem. 


updated on 6/10/2019 4:17:54 PM